Centrus Energy (LEU) Earnings and Price Action Recap
2/12/26
Centrus Energy (LEU) – Post-Earnings Sell-off Analysis
Tear Sheet – February 12, 2026
What Happened
Centrus Energy (NYSE: LEU) declined approximately 20% following its Q4/FY 2025 earnings release on February 10. The sell-off was driven by a 44% EPS miss, Technical Solutions margin collapse, flat 2026 guidance, and massive near-term capex with long-dated returns.
Q4 2025: The Miss
Revenue: 146.2M (vs. 147.1M consensus, -3.6% YoY).
Diluted EPS: 0.79 dollars (vs. 1.41 consensus, -44% miss; vs. 3.20 prior year, -75.3%).
Gross profit: 35.0M (-43.4% YoY). Net income: 17.8M (-66.8% YoY).
Technical Solutions gross profit collapsed 66% (17.6M → 6.0M) due to HALEU Phase 2 contract delays.
FY 2025: Revenue 448.7M (+1.5%), net income 77.8M (+6.3%), diluted EPS 3.90 (-12.8%). Marginal growth masked severe segment deterioration.
Why the Sell-off Was Rational
Flat 2026 guidance (425–475M) crushed growth expectations for a stock trading at 50x+ P/E.
Massive capex (350–500M in 2026) for centrifuge manufacturing with HALEU production targeted “sometime after 2030.”
Earnings quality concerns: High non-cash earnings and expected shareholder dilution.
Contingent backlog risk: 2.3B of 3.8B total backlog requires securing additional public/private investment. 900M DOE HALEU award still “subject to negotiation.”
SEQH View
The sell-off is justified by near-term fundamentals but may be overdone relative to long-term strategic value. Centrus remains the only U.S.-licensed HALEU producer, a critical bottleneck asset for the entire advanced reactor industry. The 900M DOE award and NNSA sole-source intent underscore irreplaceable government backing. The valuation reset may offer a more attractive entry point for long-term nuclear fuel cycle investors willing to underwrite execution risk and an extended timeline.
Full Report (Paid Subscribers Only)
→ Full PDF available exclusively to SEQH Capital Research paid subscribers. Upgrade to access →
